August 28, 2013
People living with HIV in North America who receive antiretroviral therapy have improving -- near normal, in fact -- life expectancy, according to new data presented at IAS 2013.
Investigators from the NA-ACCORD presented the results of their analysis of life expectancy among large cohorts in North America. The groups looked at 22,937 subjects over age 20 who were prescribed ART between 2000 and 2007. More than 82,000 patient-years of data and 1,600 deaths were included. The results showed that life expectancy at age 20 had increased from an additional 36 years in 2000-2002 to an additional 51 years in 2006-2007.
Life expectancy was lower among some demographic groups: individuals with a history of injection drug use, non-whites and individuals with a baseline CD4+ cell count less than 350 cells/mm3.
Which other studies presented at IAS 2013 will have lasting impact long after memories of the conference itself have faded? Read more of Dr. Llibre and Dr. Young's top picks.
No comments have been made.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|